• ‘Therapeutic Blood Clots’ Could Remedy Cartilage Loss from Osteoarthritis

    Bio-IT World| Scientists at the University of Wisconsin – Madison believe it could soon be possible to use people’s own blood clots to treat bone-on-bone osteoarthritis by having the material be the scaffolding that fills the space where cushioning cartilage used to be. The plan is to have the clots serve as a temporary matrix that cells will infiltrate to be exposed to a gene that encourages them to form hyaline cartilage.

    Mar 13, 2025
  • New Healthcare Security Benchmark Highlights Key Investment Priorities and Risks

    Bio-IT World| At a session in the Cybersecurity Pavilion of ViVE last month, Cormac Miller, President and CCO of Censinet, presented the company’s 2025 cybersecurity benchmark for the healthcare sector. This year’s benchmark revealed that for the third year in a row, organizations are focusing on respond and recover capabilities.

    Mar 12, 2025
  • Venture Capital Needed to Fill Gaps Left by Uncertain Government Funding

    Bio-IT World| Altitude Lab, the nonprofit formed by clinical-stage biotech company Recursion, recently launched a pre-seed venture fund to help 10 to 15 early-stage startups get through the current “period of uncertainty” around government funding—and other private investment groups will ideally follow suit over the short term.

    Mar 11, 2025
  • Pan-European Genomic Reanalysis Effort Yields Over 500 Diagnoses

    Bio-IT World| A groundbreaking collaborative effort spanning 12 European countries and Canada has successfully identified genetic causes for more than 500 previously unsolved rare disease cases. Led by the University of Tübingen in Germany, the Solve-RD (Solving the Unsolved Rare Diseases) consortium brought together 300 experts from 37 institutions to leverage advanced genomic reanalysis techniques, ultimately providing long-awaited answers to patients and their families.

    Mar 6, 2025
  • High-Performance Computing in the AI Era: Challenges and Future Prospects

    Bio-IT World| In an era where artificial intelligence (AI) dominates discussions in technology, high-performance computing (HPC) remains the backbone of scientific discovery and enterprise research. Despite its critical role, HPC often operates in the background, much like electricity—only noticed when it fails. On the latest Trends from the Trenches Podcast, Dirk Petersen, Director of the Supercomputing Center at Oregon State University, shared his insights on the evolving role of HPC and its integration into AI-driven research.

    Mar 5, 2025
  • AI to Democratize Access to Cheap, High-Throughput Cardiotoxicity Testing

    Bio-IT World| Researchers have trained an artificial intelligence (AI) model to reconstruct the electrical signals inside of heart cells based on recordings taken from outside those cells, opening the possibility of cheap, high-yielding cardiotoxicity testing using commercially available microelectrode arrays. The hope is that the U.S. Food and Drug Administration (FDA) will allow the tool to be used in lieu of inserting pipettes into cells to record signaling changes with the addition of a drug, which is both costly and cumbersome to do at scale.

    Mar 4, 2025
  • The False Dichotomy of Short Reads vs. Long Reads

    Bio-IT World| The rate of evolution of DNA sequencing technologies since the introduction of the Sanger method in the 1970s has been astounding. It’s just over 20 years since the publication of the first draft human genome and today, technologies can deliver that same information for as little as $100.

    Feb 28, 2025